Subungeal glomus tumor - a case report

Glomus tumor is a rare benign neoplasm that arises from the neuroarterial structure called a glomus body and accounts for 1% to 2% of soft tissue tumors in the hand. We present a case of a 36-year-old female who was treated for subungal glomus tumour of thumb

Eruption time of permanent first molars and incisors among female primary school children of Riyadh

To determine the mean eruption time of permanent first molars, central and lateral incisors and to compare the relationship of mean eruption time with body mass index [BMI] in Saudi female primary school children from Riyadh, Saudi Arabia. Cross sectional study. The study population comprised of 612 randomly selected primary school children of grade 1 to grade 3. The eruption time of permanent first molars, central and lateral incisors with age, height and weight were recorded. The mean age of children was 89.3 [SD 9.6] months ranging from 71 months to 109 months. The maxillary right first molar had the lowest mean eruption time of 77.4 [SD 3.9] months and the maxillary right lateral incisor was the last tooth to erupt with eruption time of 98.4 [SD 6.5] months. Furthermore, the mandibular incisors erupted significantly earlier than maxillary incisors. By the age of 100 months, 97% of the girls had all their first permanent molars erupted. There was no significant correlation observed between eruption times with BMI of the studied teeth except the maxillary right lateral incisor. However, an inverse relationship may exist between the eruption times and BMI. The Saudi female primary school children showed later eruption time of permanent first molars, central and lateral incisors when compared with the reported results of other national studies

Single dose aprotinin in routine cardiac surgery

Evidence exists that the serine protease inhibitor, aprotinin, when used in high dosage, can reduce the bleeding associated with cardiopulmonary bypass. This high dosage is particularly effective in patients at increased risk for bleeding. Less convincing information is available for regimes that use a lower dose and its place in routine cardiac surgery has not been fully resolved. Some studies have shown significant benefit from a single dose added to the cardio-pulmonary bypass prime and we re-examined this alternative. In a randomized, prospective, double-blinded study, we compared this single dose method with placebo in low risk adults undergoing a first procedure. Benefit was considered established if a significant reduction in blood loss or the use of transfused blood products were seen. We found a significant reduction in red cell transfusion but no improvement in blood loss or blood component transfusion in the treated group. This included patients maintained on aspirin as well as those not receiving aspirin. Aspirin significantly increased blood loss in both control and treatment groups and the usage of blood products in the treatment group. Aprotinin in this low, single dosage was not confirmed as an effective means of improving hemostasis following CPB in routine cardiac surgery